Background/Aims: In order to clarify an appropriate intake of docosahexaenoic acid (DHA, 22:6n–3), from the viewpoint of safety and physiological efficacy, the potential changes in lipid peroxidation and antioxidant defense in serum and tissues as well as those in serum lipid levels were examined in matured rats at the age of 1 year. Methods: Rats were given the diets containing graded levels of purified DHA (0, 1.0, 3.1 and 8.4% of total energy, en%) for 30 days (control and 1.0, 3.1 and 8.4 en% groups). Lipid peroxides and α-tocopherol levels in serum and tissues, and lipid levels in serum were measured. Results: Serum α-tocopherol concentrations in the 3.1 and 8.4 en% groups were significantly lower than those in the control group. Liver lipid peroxide levels assessed using the microsomal conjugated dienes were significantly higher in the 3.1 and 8.4 en% groups than those in the control group, and the chemiluminescence intensity and thiobarbituric acid value were significantly greater in the 8.4 en% group than in the control group. The liver α-tocopherol level decreased in response to the increases in lipid peroxide levels, but a significant difference was recognized only in the 8.4 en% group. In the kidney, no changes in lipid peroxide levels were observed, but the α-tocopherol level was significantly lower in the 8.4 en% group than in the control group. The levels of all the serum lipids including total cholesterol, HDL-cholesterol, triacylglycerols and phospholipids decreased as the dietary DHA level increased, and total cholesterol and phospholipid concentrations were significantly lower in the 3.1 and 8.4 en% groups than in the control group. Conclusion: These experimental results suggest that the dietary intake of DHA should not be more than 3 en% in matured rats to avoid the potentially chronic deleterious influences caused by lipid peroxidation in serum and tissues, and that the amelioration of serum lipid levels is recognized in rats fed DHA at 3 en% and above.

Keywords:
Docosahexaenoic acid, Intake assessment, Lipid peroxidation, α-Tocopherol, Serum lipid
This content is only available via PDF.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.